KELLY MCGRATH: Open Payments
NPI 1194194290 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 27 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $532
Food & beverage: $526Education: $7
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $164 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| GENZYME CORPORATION | 2 | $53 |
| Genentech USA, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $35 |
| Ionis Pharmaceuticals, Inc. | 1 | $27 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $16 |
Products named: DUPIXENT, Rhapsido, Xolair, CIBINQO, TEZSPIRE, DAWNZERA, ALVESCO, Ryaltris.
Industry payments across NC — which companies pay providers there.
